SAB Biotherapeutics (SABS) Non-Current Assets (2020 - 2026)
SAB Biotherapeutics (SABS) posted Non-Current Assets of $130.27 million for Q2 2026, up 525.7% from $20.82 million a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Non-Current Assets came in at $71.76 million, up 251.7% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- In prior years, SAB Biotherapeutics' Non-Current Assets was $20.4 million in FY2024 (-18.5%), $25.03 million in FY2023 (-13.1%), $28.81 million in FY2022 (-6.9%) and $30.95 million in FY2021 (+40.1%).
- Quarterly Non-Current Assets has run from a low of $20.4 million in Q4 2024 to a high of $135.69 million in Q1 2026 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last four quarters, with growth averaging 184.7% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2026, with growth of 525.7%; the weakest was Q3 2022, with a decline of 73.9%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $135.69 million (Q1 2026), $71.76 million (Q4 2025) and $70.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | 130.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130.27 Mn |
| Mar 31, 2026 | 135.69 Mn |
| Dec 31, 2025 | 71.76 Mn |
| Sep 30, 2025 | 70.17 Mn |
| Jun 30, 2025 | 20.82 Mn |
| Mar 31, 2025 | 21.82 Mn |
| Dec 31, 2024 | 20.40 Mn |
| Sep 30, 2024 | 21.26 Mn |
| Jun 30, 2024 | 22.31 Mn |
| Mar 31, 2024 | 24.42 Mn |
| Dec 31, 2023 | 25.03 Mn |
| Sep 30, 2023 | 25.21 Mn |
| Jun 30, 2023 | 26.44 Mn |
| Mar 31, 2023 | 27.64 Mn |
| Dec 31, 2022 | 28.81 Mn |
| Sep 30, 2022 | 30.33 Mn |
| Jun 30, 2022 | 31.40 Mn |
| Mar 31, 2022 | 31.30 Mn |
| Dec 31, 2021 | 30.95 Mn |
| Sep 30, 2021 | 116.16 Mn |
API Access
SAB Biotherapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();